{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:49:38Z","timestamp":1772160578582,"version":"3.50.1"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>It is controversial whether or not the most frequent male sexual dysfunctions, premature ejaculation (PE) and erectile dysfunction (ED), share pathogenetic mechanisms and treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Three scientists (C.McM., J.C., and A.A.), together with the Controversy's Editor (E.A.J.), with expertise in the area of medical treatment of PE, present different perspectives on the use of phosphodiesterase type 5 inhibitors (PDE5is) in PE. The psychological point of view is discussed by an expert in sexology (M.P.).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measure<\/jats:title>\n                    <jats:p>Outcome measures used are expert opinions supported by the critical review of the currently available literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This Controversy examines the role of nitric oxide (NO) as a neurotransmitter involved in the central and peripheral control of ejaculation, the adherence of methodology to the contemporary consensus of ideal PE drug trial design, the impact of methodology on treatment outcomes, and the role of PDE5i drugs (sildenafil, tadalafil, and vardenafil) in the treatment of PE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>While it is evident that PDE5is are the first choice in patients with comorbid ED and PE (where one may be secondary to the other), well-designed studies on the possible use of PDE5is in PE patients without ED are still limited. The issue will be less controversial when further evidence on the role of NO and PDE5 in the mechanism of ejaculation is available.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2011.02401.x","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T21:18:47Z","timestamp":1311715127000},"page":"2135-2143","source":"Crossref","is-referenced-by-count":52,"title":["The Controversial Role of Phosphodiesterase Type 5 Inhibitors in the Treatment of Premature Ejaculation"],"prefix":"10.1093","volume":"8","author":[{"given":"Emmanuele A.","family":"Jannini","sequence":"first","affiliation":[{"name":"Course of Endocrinology and Medical Sexology , Italy"},{"name":"Department of Experimental Medicine, University of L'Aquila , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"McMahon","sequence":"additional","affiliation":[{"name":"Australian Centre for Sexual Health , Leonards, NSW , Australia"},{"name":"Berry Road Medical Centre , Leonards, NSW , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juza","family":"Chen","sequence":"additional","affiliation":[{"name":"Sexual Health Clinic, Department of Urology , Israel"},{"name":"Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine , Israel"},{"name":"Tel-Aviv University , Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Aversa","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine , Italy"},{"name":"Sapienza University of Rome , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Perelman","sequence":"additional","affiliation":[{"name":"Human Sexuality Program, The New York Presbyterian Hospital , New York, NY , USA"},{"name":"Weill Medical College of Cornell University , New York, NY , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,8,1]]},"reference":[{"key":"2024032521504844000_bb0010","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1743-6109.2008.00901.x","article-title":"An evidence-based definition of lifelong premature ejaculation: Report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation","volume":"5","author":"McMahon","year":"2008","journal-title":"J Sex Med"},{"key":"2024032521504844000_bb0015","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1111\/j.1743-6109.2010.01975.x","article-title":"International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation","volume":"7","author":"Althof","year":"2010","journal-title":"J Sex Med"},{"key":"2024032521504844000_bb0020","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/j.1743-6109.2010.01782.x","article-title":"Disorders of orgasm and ejaculation in men","volume":"7","author":"Rowland","year":"2010","journal-title":"J Sex Med"},{"key":"2024032521504844000_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/j.1743-6109.2011.02289.x","article-title":"Evaluation of premature ejaculation","author":"Jannini","year":"2011","journal-title":"J Sex Med"},{"key":"2024032521504844000_bb0030","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1743-6109.2009.01560.x","article-title":"Treatment of premature ejaculation in the Asia-Pacific region: Results from a phase III double-blind, parallel-group study of dapoxetine","volume":"7","author":"McMahon","year":"2010","journal-title":"J Sex Med"},{"key":"2024032521504844000_bb0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00345-004-0486-9","article-title":"Ejaculatory disorders: Epidemiology and current approaches to definition, classification and subtyping","volume":"23","author":"Jannini","year":"2005","journal-title":"World J Urol"},{"key":"2024032521504844000_bb0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1517\/14728220802663549","article-title":"Premature ejaculation: Focus on therapeutic targets","volume":"13","author":"Abdel-Hamid","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"2024032521504844000_bb0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/molehr\/gah143","article-title":"Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens","volume":"11","author":"Mancina","year":"2005","journal-title":"Mol Hum Reprod"},{"key":"2024032521504844000_bb0050","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2005.12.050","article-title":"Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate","volume":"49","author":"Uckert","year":"2006","journal-title":"Eur Urol"},{"key":"2024032521504844000_bb0055","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.bjp.0703657","article-title":"Inhibition of neuroeffector transmission in human vas deferens by sildenafil","volume":"131","author":"Medina","year":"2000","journal-title":"Br J Pharmacol"},{"key":"2024032521504844000_bb0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.urology.2007.02.049","article-title":"Functional responses of isolated human seminal vesicle tissue to selective phosphodiesterase inhibitors","volume":"70","author":"Uckert","year":"2007","journal-title":"Urology"},{"key":"2024032521504844000_bb0065","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0031-9384(99)00100-6","article-title":"Ejaculatory abnormalities in mice lacking the gene for endothelial nitric oxide synthase (eNOS\u2013\/\u2013)","volume":"67","author":"Kriegsfeld","year":"1999","journal-title":"Physiol Behav"},{"key":"2024032521504844000_bb0070","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/0028-3908(94)90054-X","article-title":"The roles of nitric oxide in sexual function of male rats","volume":"33","author":"Hull","year":"1994","journal-title":"Neuropharmacology"},{"key":"2024032521504844000_bb0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1464-410X.2006.06290.x","article-title":"Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: A systematic review","volume":"98","author":"McMahon","year":"2006","journal-title":"BJU Int"},{"key":"2024032521504844000_bb0080","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1743-6109.2005.20351.x","article-title":"Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation","volume":"2","author":"McMahon","year":"2005","journal-title":"J Sex Med"},{"key":"2024032521504844000_bb0085","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0090-4295(90)80149-H","article-title":"Intracavernous medication for treatment of premature ejaculation","volume":"35","author":"Fein","year":"1990","journal-title":"Urology"},{"key":"2024032521504844000_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.ijir.3900630","article-title":"Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation","volume":"13","author":"Abdel-Hamid","year":"2001","journal-title":"Int J Impot Res"},{"key":"2024032521504844000_bb0095","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/S0022-5347(05)64174-2","article-title":"A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation","volume":"168","author":"Salonia","year":"2002","journal-title":"J Urol"},{"key":"2024032521504844000_bb0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0090-4295(02)02075-7","article-title":"Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation","volume":"61","author":"Chen","year":"2003","journal-title":"Urology"},{"issue":"2","key":"2024032521504844000_bb0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2605.2005.00593.x","article-title":"Correlation between ejaculatory and erectile dysfunction","volume":"28","author":"Jannini","year":"2005","journal-title":"Int J Androl"},{"key":"2024032521504844000_bb0110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/01.ju.0000132159.61156.ea","article-title":"AUA guideline on the pharmacologic management of premature ejaculation","volume":"172","author":"Montague","year":"2004","journal-title":"J Urol"},{"key":"2024032521504844000_bb0115","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1743-6109.2006.00287.x","article-title":"Subclinical erectile dysfunction: Proposal for a novel taxonomic category in sexual medicine","volume":"3","author":"Jannini","year":"2006","journal-title":"J Sex Med"},{"key":"2024032521504844000_bb0120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.ijir.3901327","article-title":"The Sexual Health Inventory for Men (SHIM): A 5-year review of research and clinical experience","volume":"17","author":"Cappelleri","year":"2005","journal-title":"Int J Impot Res"},{"key":"2024032521504844000_bb0125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1743-6109.2008.01092.x","article-title":"Screening for erectile dysfunction in men with lifelong premature ejaculation\u2014Is the Sexual Health Inventory for Men (SHIM) reliable?","volume":"6","author":"McMahon","year":"2009","journal-title":"J Sex Med"},{"key":"2024032521504844000_bb0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-200464010-00002","article-title":"Phosphodiesterase 5 inhibitors in rapid ejaculation: Potential use and possible mechanisms of action","volume":"64","author":"Abdel-Hamid","year":"2004","journal-title":"Drugs"},{"key":"2024032521504844000_bb0135","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1210\/en.2003-1699","article-title":"Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa","volume":"145","author":"Morelli","year":"2004","journal-title":"Endocrinology"},{"key":"2024032521504844000_bb0140","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1743-6109.2010.02097.x","article-title":"Efficacy and safety of dapoxetine for the treatment of premature ejaculation: Integrated analysis of results from five phase 3 trials","volume":"8","author":"McMahon","year":"2011","journal-title":"J Sex Med"},{"key":"2024032521504844000_bb0145","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00004714-199808000-00004","article-title":"Effect of SSRI antidepressants on ejaculation: A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline","volume":"18","author":"Waldinger","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"2024032521504844000_bb0150","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0090-4295(03)00131-6","article-title":"Nitric oxide and the lower urinary tract: Current concepts, future prospects","volume":"61","author":"Mamas","year":"2003","journal-title":"Urology"},{"key":"2024032521504844000_bb0155","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/j.1743-6109.2008.00836.x","article-title":"Clinical trial methodology in premature ejaculation observational, interventional, and treatment preference studies\u2014Part I\u2014Defining and selecting the study population","volume":"5","author":"McMahon","year":"2008","journal-title":"J Sex Med"},{"key":"2024032521504844000_bb0160","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1743-6109.2008.00837.x","article-title":"Clinical trial methodology in premature ejaculation observational, interventional, and treatment preference studies\u2014Part II\u2014Study design, outcome measures, data analysis, and reporting","volume":"5","author":"McMahon","year":"2008","journal-title":"J Sex Med"},{"key":"2024032521504844000_bb0165","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ijir.2009.21","article-title":"Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation","volume":"21","author":"Aversa","year":"2009","journal-title":"Int J Impot Res"},{"key":"2024032521504844000_bb0170","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.eururo.2004.07.001","article-title":"Psycho-biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions","volume":"46","author":"Corona","year":"2004","journal-title":"Eur Urol"},{"key":"2024032521504844000_bb0175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.ijir.3901250","article-title":"Sexual problems among women and men aged 40\u201380\u2003y: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors","volume":"17","author":"Laumann","year":"2005","journal-title":"Int J Impot Res"},{"key":"2024032521504844000_bb0180","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2605.2002.00368.x","article-title":"Management of premature ejaculation\u2014A comparison of treatment outcome in patients with and without erectile dysfunction","volume":"25","author":"Chia","year":"2002","journal-title":"Int J Androl"},{"key":"2024032521504844000_bb0185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1439-0272.2008.00910.x","article-title":"Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: A randomised, prospective and crossover study","volume":"41","author":"Mathers","year":"2009","journal-title":"Andrologia"},{"key":"2024032521504844000_bb0190","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0022-5347(05)68156-6","article-title":"The effects of alterations in nitric oxide levels in the paraventricular nucleus on copulatory behavior and reflexive erections in male rats","volume":"162","author":"Sato","year":"1999","journal-title":"J Urol"},{"key":"2024032521504844000_bb0195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1152\/ajpregu.2001.281.1.R269","article-title":"Central modulation of the NO\/cGMP pathway affects the MPOA-induced intracavernous pressure response","volume":"281","author":"Sato","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2024032521504844000_bb0200","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1464-410X.1997.00219.x","article-title":"Co-localization of nitric oxide synthase, neuropeptides and tyrosine hydroxylase in nerves supplying the human post-natal vas deferens and seminal vesicle","volume":"80","author":"Jen","year":"1997","journal-title":"Br J Urol"},{"key":"2024032521504844000_bb0205","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0006-8993(01)02673-7","article-title":"Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway","volume":"909","author":"Jain","year":"2001","journal-title":"Brain Res"},{"key":"2024032521504844000_bb0210","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.urology.2005.09.002","article-title":"Comparison of efficacy of sildenafil-only, sildenafil plus topical EMLA cream, and topical EMLA-cream-only in treatment of premature ejaculation","volume":"67","author":"Atan","year":"2006","journal-title":"Urology"},{"key":"2024032521504844000_bb0215","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1442-2042.2007.01606.x","article-title":"Can sildenafil treat primary premature ejaculation? A prospective clinical study","volume":"14","author":"Wang","year":"2007","journal-title":"Int J Urol"},{"key":"2024032521504844000_bb0220","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.mou.0000182327.79572.fd","article-title":"Epidemiology of premature ejaculation","volume":"15","author":"Jannini","year":"2005","journal-title":"Curr Opin Urol"},{"key":"2024032521504844000_bb0225","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.eururo.2006.07.004","article-title":"The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: Prevalence, comorbidities, and professional help-seeking","volume":"51","author":"Porst","year":"2007","journal-title":"Eur Urol"},{"key":"2024032521504844000_bb0230","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-1119(98)00303-5","article-title":"Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3\u2032,5\u2032-cyclic nucleotide phosphodiesterase","volume":"216","author":"Loughney","year":"1998","journal-title":"Gene"},{"key":"2024032521504844000_bb0235","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-2999(01)01620-X","article-title":"Nucleotide-evoked relaxation of rat vas deferens: Possible mechanisms","volume":"436","author":"Bultmann","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"2024032521504844000_bb0240","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1743-6109.2008.01085.x","article-title":"Effects of phosphodiesterase inhibitors on the contractile responses of isolated human seminal vesicle tissue to adrenergic stimulation","volume":"6","author":"Uckert","year":"2009","journal-title":"J Sex Med"},{"key":"2024032521504844000_bb0245","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0031-9384(95)02272-4","article-title":"Sexual behavior in male rats after nitric oxide synthesis inhibition","volume":"60","author":"Bialy","year":"1996","journal-title":"Physiol Behav"},{"key":"2024032521504844000_bb0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ijir.2010.34","article-title":"Is there a role for phosphodiesterase type-5 inhibitors in the treatment of premature ejaculation?","volume":"23","author":"Aversa","year":"2011","journal-title":"Int J Impot Res"},{"key":"2024032521504844000_bb0255","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/humrep\/15.1.131","article-title":"Effects of sildenafil (Viagra) administration on seminal parameters and post-ejaculatory refractory time in normal males","volume":"15","author":"Aversa","year":"2000","journal-title":"Hum Reprod"},{"key":"2024032521504844000_bb0260","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s11255-010-9710-2","article-title":"In vitro measurement of ejaculation latency time (ELT) and the effects of vardenafil on ELT on lifelong premature ejaculators: Placebo-controlled, double-blind, cross-over laboratory setting","volume":"42","author":"Gokce","year":"2010","journal-title":"Int Urol Nephrol"},{"key":"2024032521504844000_bb0265","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000112607","article-title":"Tadalafil and fluoxetine in premature ejaculation: Prospective, randomized, double-blind, placebo-controlled study","volume":"80","author":"Mattos","year":"2008","journal-title":"Urol Int"},{"key":"2024032521504844000_bb0270","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2605.2002.00371.x","article-title":"Sexological approach to ejaculatory dysfunction","volume":"25","author":"Jannini","year":"2002","journal-title":"Int J Androl"},{"key":"2024032521504844000_bb0275","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0090-4295(01)01151-7","article-title":"Prevalence of chronic prostatitis in men with premature ejaculation","volume":"58","author":"Screponi","year":"2001","journal-title":"Urology"},{"key":"2024032521504844000_bb0280","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1743-6109.2008.01177.x","article-title":"The sexual tipping point: A mind\/body model for sexual medicine","volume":"6","author":"Perelman","year":"2009","journal-title":"J Sex Med"},{"key":"2024032521504844000_bb0285","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/j.1743-6109.2010.01824.x","article-title":"Organic vs. psychogenic? The Manichean diagnosis in sexual medicine","volume":"7","author":"Jannini","year":"2010","journal-title":"J Sex Med"},{"key":"2024032521504844000_bb0290","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1464-410X.2008.07790.x","article-title":"Identifying constructs and criteria for the diagnosis of premature ejaculation: Implication for making errors of classification","volume":"102","author":"Althof","year":"2008","journal-title":"BJU Int"},{"key":"2024032521504844000_bb0295","article-title":"2010 A prospective randomized, double-blind, placebo-controlled, parallel group, multicenter study of the efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with phosphodiesterase-5 inhibitor.","author":"Development JJPRa","journal-title":"Clinicaltrialsgov"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515336225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515336225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/8\/8\/2135\/47245357\/jsm_8_8_2135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/8\/8\/2135\/47245357\/jsm_8_8_2135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T18:02:50Z","timestamp":1711389770000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/8\/8\/2135\/6843960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,1]]},"references-count":58,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,1]]},"published-print":{"date-parts":[[2011,8,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02401.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13382996.14750233","asserted-by":"object"}]},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,8]]},"published":{"date-parts":[[2011,8,1]]}}}